| Title : Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial - Lannfelt_2008_Lancet.Neurol_7_779 |
| Author(s) :
Lannfelt L , Blennow K , Zetterberg H , Batsman S , Ames D , Harrison J , Masters CL , Targum S , Bush AI , Murdoch R , Wilson J , Ritchie CW |
|
Ref :
Lancet Neurol , 7 :779 , 2008 |
| Abstract : Lannfelt_2008_Lancet.Neurol_7_779 |
| ESTHER : Lannfelt_2008_Lancet.Neurol_7_779 |
| PubMedSearch : Lannfelt_2008_Lancet.Neurol_7_779 |
| PubMedID: 18672400 |